Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/1996
05/23/1996CA2205029A1 Delivery system
05/23/1996CA2205017A1 Method for the detection of ras oncogenes, in particular the k-ras oncogene
05/23/1996CA2204914A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/23/1996CA2204871A1 Methods for modulating transcription from the amyloid .beta.-protein precursor (app) promoter
05/23/1996CA2204770A1 Process for functional expression of the para cation channel
05/23/1996CA2204665A1 Beta3 integrin subunit specific polypeptides, cdnas which encode these polypeptides and methods of producing these polypeptides
05/23/1996CA2204629A1 In vitro induction of dopaminergic cells
05/23/1996CA2204379A1 Sensory and motor neuron derived factor (smdf)
05/23/1996CA2203934A1 Targeted t lymphocytes
05/23/1996CA2203654A1 Human stanniocalcin-alpha
05/23/1996CA2203565A1 Synthesis of peptide nucleic acids (pnas) and analogues via submonomer approach
05/23/1996CA2203375A1 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996CA2203133A1 Purification of hemoglobin
05/22/1996EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
05/22/1996EP0712934A2 Proteins with fibrinolytic and anticoagulant activity
05/22/1996EP0712931A2 Interferon-gamma production inducing polypeptide, monoclonal antibody, and agent for interferon-gamma susceptive disease
05/22/1996EP0712930A2 A transgenic nonhuman animal model for diabetes
05/22/1996EP0712929A2 A transgenic nonhuman animal deficient in T-cells
05/22/1996EP0712928A2 T cell antigen receptor
05/22/1996EP0712926A2 Fish pancreatic disease virus
05/22/1996EP0712863A1 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use
05/22/1996EP0712862A2 Selective acylation of epsilon-amino groups
05/22/1996EP0712861A2 Acylated insulin analogs
05/22/1996EP0712496A1 Quantitation of carbohydrate deficient transferrin in high alcohol consumption by hplc
05/22/1996EP0712448A1 Surface coating method
05/22/1996EP0712414A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences
05/22/1996EP0712413A1 Antimicrobial proteins
05/22/1996EP0712314A1 Monogenous preparations of cytotoxic conjugates
05/22/1996EP0712313A1 Pro-cytotoxic drug conjugates for anticancer therapy
05/22/1996EP0565548B1 Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines
05/22/1996EP0506971B1 Peptide with activity of inhibiting phospholipase a2 originating in inflamed part
05/22/1996EP0486526B1 Tumour necrosis factor binding ligands
05/21/1996US5519120 Urokinase-type plasminogen activator receptor antibodies
05/21/1996US5519119 Muteins of TNF pharmaceutical compositions and a method of making
05/21/1996US5519118 Human MDM2 protein involved in human tumors
05/21/1996US5519117 Polypeptide sequences as anticarcinogenic agents
05/21/1996US5519115 Reverse antimicrobial peptides
05/21/1996US5519114 Retroviral superantigens, superantigen peptides, and methods of use
05/21/1996US5519004 Elastomeric polypeptide matrices for preventing adhesion of biological materials
05/21/1996US5519003 WD-40-derived peptides and uses thereof
05/21/1996US5519001 CETP inhibitor polypeptide antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
05/21/1996US5519000 Tumor necrosis factor inhibitors
05/21/1996US5518916 Cloned Babesia DNA
05/21/1996US5518914 Growth medium containing a complex of prealbumin, a retinoid and retinol-binding protein used to enhance B cell growth
05/21/1996US5518912 A pure enzyme endogenous to biological cells of the skin of xenopus
05/21/1996US5518901 Methods for adapting nucleic acid for detection, sequencing, and cloning using exonuclease
05/21/1996US5518899 Propagation with polypeptides and carbohydrates for treatment of viricides
05/21/1996US5518897 Controlling mosquitoes and black flies, proteins, insecticides
05/21/1996US5518888 Imaging metastasized colorectal cancer, toxtin peptides less than 25 units
05/21/1996US5518885 ERBB2 promoter binding protein in neoplastic disease
05/21/1996US5518881 Transfected cell lines expressing autoantigens and their use in immunoassays for the detection of autoimmune disease
05/21/1996US5518880 X-linked severe combined immunodeficiency diseases
05/21/1996US5518735 Anticoagulants administered by mouth
05/21/1996US5518724 Infectious bursal disease virus
05/21/1996US5518723 Vaccines containing antibodies and epitopes
05/21/1996CA2064092C Efficient directional genetic cloning system
05/21/1996CA1338344C Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
05/21/1996CA1338338C Process for the preparation of foreign proteins in streptomycetes
05/18/1996CA2162986A1 Proteins having fibrinolytic and coagulation-inhibiting properties
05/17/1996WO1996014580A1 Assay for marker of human polymorphonuclear leukocyte elastase activity
05/17/1996WO1996014579A1 The use of a bmp protein receptor complex for screening bone metabolism actives and cells co-transfected with a type ii bmp receptor and a type i bmp receptor
05/17/1996WO1996014422A1 Process for bacterial production of heterologous polypeptides with disulphide bonds
05/17/1996WO1996014418A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996WO1996014416A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
05/17/1996WO1996014415A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
05/17/1996WO1996014414A1 Genetic control of flowering
05/17/1996WO1996014413A1 Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus
05/17/1996WO1996014412A2 cDNA ENCODING A BMP TYPE II RECEPTOR
05/17/1996WO1996014411A1 Methods for the diagnosis of glaucoma
05/17/1996WO1996014410A1 Human scf, a splice variant thereof, its pharmaceutical use
05/17/1996WO1996014409A1 Production of recombinant peptides as natural hydrophobic peptide analogues
05/17/1996WO1996014407A1 Recombinant alternaria alternata allergens
05/17/1996WO1996014402A1 Insecticidal composition containing heterorhabditis nematodes and process
05/17/1996WO1996014393A1 H. pylori fermentation process
05/17/1996WO1996014336A1 Novel oxyntomodulin
05/17/1996WO1996014335A1 Cartilage-derived morphogenetic proteins
05/17/1996WO1996014334A1 IDENTIFICATION OF THE p21WAF1-PCNA INTERACTION SITE AND THERAPEUTIC APPLICATIONS THEREOF
05/17/1996WO1996014332A1 Retroviral vectors containing recombinant cmv-ie/hiv-tar/moloney murine leukemia virus long terminal repeats
05/17/1996WO1996014331A1 Modified neuropeptide y receptors
05/17/1996WO1996014328A1 Tumor necrosis factor-gamma
05/17/1996WO1996014111A1 Golf club receptacle
05/17/1996WO1996014089A1 Methods and compositions for the diagnosis of flea allergies
05/17/1996WO1996014088A1 Attenuated canine parvovirus vaccine
05/17/1996WO1996014087A1 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
05/17/1996WO1996014086A1 Combined meningitis vaccine
05/17/1996WO1996014077A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
05/17/1996WO1996014074A1 Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
05/17/1996WO1996014061A1 Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods
05/17/1996WO1996011279A3 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
05/17/1996WO1996010639A3 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
05/17/1996WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
05/17/1996WO1996002646A3 Growth control for cells encapsulated within bioartificial organs
05/17/1996CA2689871A1 Combined meningitis vaccine
05/17/1996CA2204645A1 Novel oxyntomodulin
05/17/1996CA2204619A1 Method for enhancing the immunogenicity of an immunogenic compound or hapten, and use thereof for preparing vaccines
05/17/1996CA2204618A1 Respiratory syncytial virus protein g expressed on bacterial membrane
05/17/1996CA2204511A1 Production of recombinant peptides as natural hydrophobic peptide analorues
05/17/1996CA2204510A1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine
05/17/1996CA2204491A1 Modified neuropeptide y receptors
05/17/1996CA2204362A1 Recombinant alternaria alternata allergens
1 ... 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 ... 2916